MC1R Chromosome 16

Melanocortin 1 receptor
42 variants 42 Health Risk

Upload your DNA to see your personal genotypes for variants in MC1R.

What This Gene Does
This intronless gene encodes the receptor protein for melanocyte-stimulating hormone (MSH). The encoded protein, a seven pass transmembrane G protein coupled receptor, controls melanogenesis. Two types of melanin exist: red pheomelanin and black eumelanin. Gene mutations that lead to a loss in function are associated with increased pheomelanin production, which leads to lighter skin and hair color. Eumelanin is photoprotective but pheomelanin may contribute to UV-induced skin damage by generating free radicals upon UV radiation. Binding of MSH to its receptor activates the receptor and stimulates eumelanin synthesis. This receptor is a major determining factor in sun sensitivity and is a genetic risk factor for melanoma and non-melanoma skin cancer. Over 30 variant alleles have been identified which correlate with skin and hair color, providing evidence that this gene is an important component in determining normal human pigment variation. [provided by RefSeq, Jul 2008]
Gene Info
Gene Group
Melanocortin receptors
Locus Type
gene with protein product
Location
16q24.3
Ensembl
ENSG00000258839
Associated Conditions (19)
Melanoma
cutaneous malignant
susceptibility to
5
SKIN/HAIR/EYE PIGMENTATION
VARIATION IN
2
Tyrosinase-positive oculocutaneous albinism
Increased analgesia from kappa-opioid receptor agonist
female-specific
Skin/hair/eye pigmentation 2
red hair/fair skin
ALBINISM
OCULOCUTANEOUS
TYPE II
MODIFIER OF
MC1R-related disorder
Skin and Hair Hypopigmentation
UV-induced skin damage
Key Variants
All Variants (42)
RSID Category Clinical Significance Conditions
RS1110400 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS11547464 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS12102534 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS1260091224 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS1374244663 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS1805006 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS1805007 Health Risk Conflicting classifications of pathogenicity Skin/hair/eye pigmentation 2, red hair/fair skin, Increased analgesia from kappa-opioid receptor agonist
RS200000734 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS201171524 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS201326893 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS201489928 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS201533137 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS201632257 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS2045699975 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS33932559 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS34474212 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS367985661 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS368507952 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS369016553 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS370472871 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS371618933 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS372152373 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS373344683 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS373703770 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS376670171 Health Risk Conflicting classifications of pathogenicity Tyrosinase-positive oculocutaneous albinism, Melanoma, cutaneous malignant
RS546618600 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS553516665 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS554831935 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS564161331 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS745994833 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS750618617 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS754971328 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS760458744 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS763647934 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS765848904 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS773260532 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS773395822 Health Risk Conflicting classifications of pathogenicity Melanoma, cutaneous malignant, susceptibility to
RS1805009 Health Risk Conflicting classifications of pathogenicity; risk factor Skin/hair/eye pigmentation 2, red hair/fair skin, Tyrosinase-positive oculocutaneous albinism
RS143395134 Health Risk Likely pathogenic Tyrosinase-positive oculocutaneous albinism, Skin and Hair Hypopigmentation, Tyrosinase-positive oculocutaneous albinism
RS2045705764 Health Risk Pathogenic/Likely pathogenic SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2
RS104894523 Health Risk risk factor UV-induced skin damage, susceptibility to, UV-induced skin damage
RS1310082996 Health Risk risk factor UV-induced skin damage, susceptibility to, UV-induced skin damage
Sign Up to Analyze Your DNA Log In